India's Cohance Lifesciences drops on quarterly profit fall

Cohance Lifesciences

29/05/2025 09:44

** Cohance Lifesciences COHA.NS shares down 3.4% to 1,070.7 rupees

** Pharma co's Q4 consol net profit falls 21% y/y as expenses surged 81% due to investment plans; rev grows nearly 59%

** Q1FY26 revenue growth to be muted, would pick-up in H2FY26 - Co

** Stock rated "strong buy" on avg, median PT 1,402.5 rupees - data compiled by LSEG

** COHA down 6% YTD

 (Reporting by Manvi Pant in Bengaluru)

 ((Manvi.Pant@thomsonreuters.com; +918447554364;))